Renal insufficiency, chronic
Clinical trials for Renal insufficiency, chronic explained in plain language.
Never miss a new study
Get alerted when new Renal insufficiency, chronic trials appear
Sign up with your email to follow new studies for Renal insufficiency, chronic, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can calming inflammation shield the heart?
Disease control Not yet recruitingThis trial tests whether clazakizumab, an experimental anti-inflammatory drug, can lower a blood marker of inflammation called hsCRP in adults who have elevated levels and are at increased risk for heart problems. Participants must have conditions like established heart disease, …
Matched conditions: RENAL INSUFFICIENCY, CHRONIC
Phase 2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Can a kidney drug stop acute injury from becoming chronic?
Disease control Not yet recruitingThis trial tests whether finerenone, a drug already used for chronic kidney disease, is safe and tolerable for people hospitalized with acute kidney injury (AKI). About 72 adults with moderate-to-severe AKI will receive either finerenone or a placebo once daily for up to 45 days,…
Matched conditions: RENAL INSUFFICIENCY, CHRONIC
Sponsor: Jean-Maxime Côté • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
New drug combo aims to slow kidney failure in High-Risk patients
Disease control Not yet recruitingThis phase 3 trial tests whether a combination of two drugs (balcinrenone and dapagliflozin) works better than dapagliflozin alone for people with advanced chronic kidney disease (stages 3b and 4). About 2,800 participants will take the combination or a placebo daily, alongside s…
Matched conditions: RENAL INSUFFICIENCY, CHRONIC
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New hope for cancer pain in seniors with kidney disease?
Symptom relief Not yet recruitingThis study looks at whether hydromorphone sustained-release tablets can safely relieve moderate to severe cancer pain in elderly patients who also have kidney issues. Researchers will compare these patients to those with normal kidney function, monitoring pain relief, kidney func…
Matched conditions: RENAL INSUFFICIENCY, CHRONIC
Sponsor: Taian Cancer Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC